The Expanding Role of (U)HPLC and LC-MS in Next-Generation Biopharmaceuticals

Join this webinar to learn about CTFS GrantPlan’s AI-powered protocol ingestion to move faster from protocol to budget by automatically extracting key study details, visit schedules, and assessments. It will cover how a human-in-the-loop approach balances automation with expert oversight, resulting in faster and more accurate study budgets.

Register Free: https://www.biopharminternational.com/bp_w/(U)HPLC

Event Overview:

Liquid chromatography (LC) technologies continue to evolve as analytical demands grow across large-molecule drugs, biotherapeutic, and cell and gene therapy (CGT) applications. This expert-led webinar explores current advancements in (U)HPLC and LC-MS, highlighting how each technique addresses the increasingly complex analytical landscape.

The session will also delve into the unique analytical complexities of biotherapeutic and CGT platforms and how modern LC-MS workflows enhance specificity, sensitivity, and structural elucidation. Attendees will gain a deeper understanding of how chromatography and LC-MS are shaping quality, safety, and efficacy assessment in next-generation therapeutics.

Key Learning Objectives:

• Identify current trends driving the adoption of LC-MS for large-molecule biotherapeutics and CGT development, manufacturing, and quality control.
• Learn how LC-MS workflows are applied to characterize complex biologics.
• Understand how LC-MS supports quality, safety, and regulatory expectations for biotherapeutic and CGT products.

Who Should Attend:

• Pharmaceutical and biotech roles: VP of manufacturing, lab manager/director, senior scientist, scientist, QA/QC director, process development engineer, senior analytical scientist, analytical scientist
• Roles in academia: Analytical chemist, biochemist

Moderator:

Anthony Edge, Ph.D.
President, UK Chromatographic Society

Tony Edge is a chromatography expert with extensive experience in biopharma research and manufacturing. He is president of the UK Chromatographic Society in the United Kingdom, and chair of the International Symposium on Chromatography’s Permanent Scientific Committee. In 2008, Edge was awarded the Royal Society of Chemistry Desty Memorial Lecture for Innovation in Separation Science. He holds a PhD in chemistry from the University of Leeds.

Speakers:

Atis Chakrabarti, Ph.D.
Senior Applications Scientist, Avantor

Atis Chakrabarti, Ph.D., has 15-plus years of experience in analytical and process chromatography. He brings broad expertise in HPLC, including the purification of peptides, mAbs, recombinant proteins, and ADCs. He has led application teams and CDMO programs, delivering customized purification solutions. He is a trusted technical partner, known for his experience in feasibility studies for chiral and achiral separations and process development.

Daniel Spencer, Ph.D.
Head of Development, Ludger Limited

Daniel Spencer, Ph.D., is head of development at Ludger, specializing in glycoscience tools, standards, and analytical services. He leads R&D programs that develop high-throughput glycomics workflows and translate complex glycomic data into applications such as biomarker discovery and biopharmaceutical quality assessment, with particular expertise in LC-MS. Spencer is an honorary associate professor at University College London.

Yan-Bo Yang, Ph.D.
President and CEO, BioPharmDev

Yan-Bo Yang, Ph.D., has over 30 years of experience in analytical chemistry, particularly in separation sciences and chromatography technology for pharmaceutical, nutritional supplement, medical device, and biotech applications, including both small molecules and large biologics. Yang is knowledgeable in drug product development, cGMP, quality systems, and preparation for FDA submissions. Yang is the president of AOAC International Southern California.

Register Free: https://www.biopharminternational.com/bp_w/(U)HPLC